Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-05 Sale |
2024-01-08 6:14 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
5,994 | $10.79 | $64,656 | 107,503 (Direct) |
View |
2023-12-11 Sale |
2023-12-11 8:00 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
886 | $9.1301 | $8,089 | 1,997 (Direct) |
View |
2022-12-12 Sale(A) |
2022-12-23 8:00 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
887 | $6.01 | $5,331 | 2,883 (Direct) |
View |
2022-12-12 Sale |
2022-12-14 8:00 pm |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
887 | $6.01 | $5,331 | 2,883 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-01-05 Exercise |
2024-01-08 6:14 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
10,500 | $0 | 107,503 (Direct) |
View |
2024-01-05 Option Award |
2024-01-08 6:14 pm |
N/A 2034-01-04 |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
80,000 | $0 | 107,503 (Direct) |
View |
2023-12-11 Exercise |
2023-12-11 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
1,550 | $0 | 1,997 (Direct) |
View |
2023-01-05 Option Award |
2023-01-06 8:00 pm |
N/A 2033-01-04 |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
78,500 | $0 | 78,500 (Direct) |
View |
2022-12-12 Exercise(A) |
2022-12-23 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
1,550 | $0 | 2,883 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 8:00 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
1,550 | $0 | 2,883 (Direct) |
View |
2022-03-10 Option Award |
2022-03-11 9:00 pm |
N/A 2032-03-09 |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
Ownership |
2022-03-04 9:20 pm |
N/A N/A |
Zymeworks Inc. | ZYME | Astle Christopher SVP & Chief Financial Officer |
0 | $0 | 21,020 (Direct) |
View |